AGN

Wednesday’s Vital Data: Pfizer Inc. (PFE), Allergan plc Ordinary Shares (AGN) and AT&T Inc. (T)

Options activity spiked on Pfizer (PFE) and Alergan (AGN) as their merger deal fell apart, while AT&T (T) call volume soared ahead of T’s ex-dividend.

Wall Street Hits Snag on Strength in Treasuries

In the end, the Dow Jones Industrial Average fell 0.8%, the S&P 500 lost 1%, the Nasdaq Composite dropped 1% and the Russell 2000 finished the day 1.1% lower.

Why Marvell Technology Group Ltd. (MRVL), Pfizer Inc. (PFE) and Valeant Pharmaceuticals Intl Inc (VRX) Are 3 of Today’s Best Stocks

There were some bright spots on Wall Street and, interestingly, it was controversy in one form or another that helped MRVL, PFE and VRX to rank as three of today's best stocks.

Why Allergan plc Ordinary Shares (AGN), Baker Hughes Incorporated (BHI) and GoDaddy Inc (GDDY) Are 3 of Today’s Worst Stocks

Tuesday was particularly tough on owners of Allergan plc (AGN), Baker Hughes (BHI) and Godaddy (GDDY). Here's the deal.

Allergan, Pfizer Inc. Fall Prey to Tax-Inversion Hawks (AGN, PFE)

Pfizer (PFE) and Allergan (AGN) could still team up if they wanted to, but with new Treasury rules in place, why would they want to?

3 Stocks to Watch on Tuesday: Tesla Motors Inc (TSLA), Walt Disney Co (DIS) and Allergan plc Ordinary Shares (AGN)

Tesla (TSLA) missed its Q1 delivery expectations, Allergan's (AGN) deal with Pfizer may be hampered by new Treasury rules and Disney's (DIS) COO steps down.

Why Allergan plc Ordinary Shares (AGN), Deere & Company (DE) and Micron Technology, Inc. (MU) Are 3 of Today’s Worst Stocks

Allergan plc (AGN), Deere & Company (DE) and Micron Technology (MU) never even had a fighting chance of making gains on Thursday.

3 Mega Mergers That Might Not Happen (AGN, BHI, ODP)

The stocks of ODP, BHI and AGN are all trading at significant discounts to their buyout prices because the market anticipates hurdles ahead.

73 Stock Trades for Your Week

During these times it pays to stay on top of the latest profit opportunities. Today's blog post should be a great place to start with these 73 stock trades

Investor Alert: Know Before You Buy These 57 Blue Chips

It pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with the latest Portfolio Grader marks

Tuesday’s Vital Data: Netflix, Inc. (NFLX), Valeant Pharmaceuticals Intl Inc (VRX) and Yahoo! Inc. (YHOO)

Netflix (NFLX) put options get popular after a downgrade, Valeant (VRX) has itself a horrible day and Yahoo (YHOO) is boosted by hedge-fund activist comments.

Why Valeant Pharmaceuticals Intl Inc (VRX), Endo International plc (ENDP) and Southwestern Energy Company (SWN) Are 3 of Today’s Worst Stocks

Valeant Pharmaceuticals (VRX), Endo International (ENDP) and Southwestern Energy (SWN) couldn't win for losing on Monday. Here's the deal.

2 Drug Stocks To Buy For Safe Dividends And 20% Gains

With all the talk on the campaign trail about drug costs, it's safe to say the pharmaceutical industry is under siege. But these drug stocks are solid buys

Pfizer Inc.: Is PFE Stock a Buy After Allergan?

Pfizer stock has been reborn thanks to its merger with Allergan. It's hard to tell if PFE is an attractive value, but it's certainly an attractive stock.

62 Stock Upgrades (and Downgrades) for the Week

During these time it pays to stay on top of the latest profit opportunities. Today's blog post is be a great place to start with these 62 trades to make

Pfizer Inc. Stock: A Good Buy While the Pharma Industry Is Down (PFE)

Between a planned merger with Allergan and a strong pipeline of drugs, PFE stock is a solid choice at a great price.

Respect the Pipeline! Pfizer Is a Bargain (PFE)

Pfizer stock has sagged lately, but the deal with Allergan should provide a nice boost in the coming years because of its range of drugs.

10 Biggest Mergers and Acquisitions of 2015

2016 was a record year for M&A -- totaling more than $5 trillion. These are the deals that led the way.

The 5 Best Mutual Funds to Buy for 2016

Nailing down the best mutual funds for 2016 was no easy task but we found five that could be top performers.